Stay current: Follow Cardiac Interventions Today on Twitter @cardiacinterv



Teleflex Receives FDA Clearance for TrapLiner Catheter

February 22, 2017 -- Teleflex Incorporated announced US Food and Drug Administration 510(k) clearance and the United States commercial launch of its TrapLiner catheter. T…

Cost Benefits of Transradial PCI Studied Among Medicare Beneficiaries

February 24, 2017 -- Findings from an evaluation of the current percutaneous coronary intervention (PCI) care pathways in the United States were published by Amit P. Amin…

Boston Scientific Voluntarily Recalls All Lotus TAVR Devices

February 23, 2017 -- In a Form 8-K report to the US Securities and Exchange Commission (SEC), Boston Scientific announced a voluntary removal of all Lotus transcathe…

Teleflex Completes Acquisition of Vascular Solutions

February 22, 2017 -- Teleflex Incorporated announced last week the completion of its acquisition of Vascular Solutions, Inc., a developer of clinical solut…

Featured Center




Current Supplement

2017 Buyer’s Guide


This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.